Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Haag, D. M. Peters, B. Kojonazarov, S. Kraut, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, A. Möller, M. L. Schmitz, N. Weissmann (Giessen, Germany; Herston, Brisbane, Australia). Siah2 in pulmonary hypertension and right ventricular hypertrophy. Eur Respir J 2013; 42: Suppl. 57, 494

Member's Comments

No comment yet.

Related content which might interest you: Myocardial metabolic changes in experimental non-hypertrophied and hypertrophied right ventricular failure Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Right ventricular lymphatic insufficiency is associated with increased edema in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Right ventricular hypertrophy or dilatation in the pulmonary arterial hypertension: Is there a difference in the autonomic imbalance? Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2 Source: Eur Respir J 2011; 37: 823-834 Year: 2011 Inhibition of p38 MAPK improves heart function in experimental pressure-overload induced right ventricular hypertrophy and failure Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Chronic thromboembolic pulmonary hypertension: animal models Source: Eur Respir J 2013; 41: 1200-1206 Year: 2013 Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2013; 41: 224-232 Year: 2013 Effects of epoprostenol infusion on myocardial inflammation in acute afterload-induced right ventricular failure Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights Year: 2015 Left ventricular systolic torsion is correlated to right ventricular dilation in pulmonary hypertension patients Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases Year: 2008 Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Echocardiographic indices of right ventricular function in pediatric pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015